What is Nalu Bio?
Nalu Bio operates at the intersection of biotechnology and consumer wellness, specializing in the discovery and production of high-purity cannabinoid ingredients. Unlike traditional extraction methods, the company utilizes advanced synthetic biology to create predictably performing compounds. This approach addresses the inherent volatility and supply chain inconsistencies often found in the legal cannabinoid market, positioning Nalu Bio as a vital infrastructure provider for pharmaceutical and wellness brands seeking reliable, high-quality inputs.
How much funding has Nalu Bio raised?
Nalu Bio has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2023): $12M with participation from Flybridge Capital Partners, Bonaventure Equity, and Intrinsic Capital Partners
Key Investors in Nalu Bio
Flybridge Capital Partners
Flybridge is an early-stage venture capital fund with over 20 years of investing experience, focusing on supporting ambitious founders and AI-native startups.
Bonaventure Equity
Bonaventure Equity is a specialized investment firm managing a multi-million dollar cannabis fund, providing proven frameworks for success in the private company landscape.
Intrinsic Capital Partners
Intrinsic Capital Partners focuses on life science and technology businesses within the legal cannabinoid market, applying institutional discipline to scale supply chain solutions.
What's next for Nalu Bio?
Looking ahead, Nalu Bio is poised to leverage its recent capital injection to expand its manufacturing capacity and deepen its research and development pipeline. The strategic focus will likely shift toward optimizing production efficiency and securing regulatory milestones that facilitate broader market adoption. By maintaining a disciplined approach to scaling, the company is set to capitalize on the growing demand for standardized cannabinoid ingredients, ultimately aiming to set a new benchmark for safety and efficacy in the industry. The support from its current investor base provides not only the necessary liquidity but also the operational expertise required to navigate the complex regulatory landscape of the life sciences sector.
See full Nalu Bio company page
